Company / Current Liabilities
Tandem Diabetes Care Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$242.7M
FY2025
5-year range
$131.9M / $247.0M
FY2021-FY2025
Trend
-1.8%
vs FY2024
Sector context
#95 of 160
Health Care
What the data says
At $243M, Tandem Diabetes Care's current liabilities ranks #66 of 160 in the Health Care sector. Increased from $195M to $243M over the past 2 years.
Based on SEC 10-K filings.
$243M in FY2025 with a 5-year CAGR of +18.5%.
Increased from $195M to $243M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +13.7%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Sector benchmark
#66 of 160 in Health CareTop 41% of 160This company $242.7M Sector average $4.5B
▼
-94.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.5%, indicating consistent growth.
- In FY2025, current liabilities decreased 1.8% year-over-year.
- Ranks #95 out of 160 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $242.7M | -1.8% |
| FY2024 | $247.0M | +26.5% |
| FY2023 | $195.3M | +18.1% |
| FY2022 | $165.3M | +25.4% |
| FY2021 | $131.9M | +27.0% |
| FY2020 | $103.9M | +4.5% |
| FY2019 | $99.4M | +49.9% |
| FY2018 | $66.3M | +83.7% |
| FY2017 | $36.1M | +14.6% |
| FY2016 | $31.5M | +18.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026